Articles with "mucinous component" as a keyword



Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.

Sign Up to like & get
recommendations!
Published in 2019 at "Clinical colorectal cancer"

DOI: 10.1016/j.clcc.2019.02.007

Abstract: BACKGROUND Adenocarcinoma with mucinous histology or mucinous component are histologic subtypes of metastatic colorectal cancers (mCRCs) with limited benefit from cytotoxic agents. Their sensitivity to anti-epithelial growth factor receptors (EGFRs) is not clear. PATIENTS AND… read more here.

Keywords: mucinous component; histology mucinous; colorectal; histology ... See more keywords
Photo from wikipedia

Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation

Sign Up to like & get
recommendations!
Published in 2020 at "Modern Pathology"

DOI: 10.1038/s41379-020-0496-1

Abstract: Mucinous colorectal adenocarcinoma (CRC) is conventionally defined by extracellular mucin comprising >50% of the tumour area, while tumours with ≤50% mucin are designated as having a mucinous component. However, these definitions are largely arbitrary and… read more here.

Keywords: status; braf mutation; grade; mucinous component ... See more keywords
Photo by nci from unsplash

Colorectal cancer with mucinous component compared to clinicopathological and molecular features as mucinous adenocarcinoma.

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2017.35.15_suppl.e15166

Abstract: e15166Background: CRC can be divided into 3 groups: regular adenocarcinoma (RA), mucinous adenocarcinoma (MA), and adenocarcinoma with mucinous component (MC, mucin formation read more here.

Keywords: mucinous component; mucinous adenocarcinoma; component compared; colorectal cancer ... See more keywords

Predictive value of intratumoral-metabolic heterogeneity derived from 18F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2023.1065744

Abstract: Purpose/background Microsatellite instability (MSI) status is a significant biomarker for the response to immune checkpoint inhibitors, response to 5-fluorouracil-based adjuvant chemotherapy, and prognosis in colorectal carcinoma (CRC). This study investigated the predictive value of intratumoral-metabolic… read more here.

Keywords: heterogeneity; intratumoral metabolic; metabolic heterogeneity; fdg pet ... See more keywords